Figure 5. V3 peptide affects heparin interference with TCA FIV SU binding to CXCR4.

Panel A and B represent PPRcr and 34TF10 SU-Fc binding to 3201 cells, respectively. All peptides were used at 50 µg/ml as final concentration. Heparin was used at 20 µg/ml. Values are inhibition percentage calculated as described in “Materials and Methods”. Results are means and SD for three independent determinations. ***p<0.001; **p<0.01; *p<0.05; as compared to the heparin treatment group without peptides.